The protein level of exosomal PDL1 derived from head and neck cancer cells is significantly associated with disease progression, number of tumor nodules, and tumor stage, which may downregulate CD69 antigen level of cytotoxic T cells and reduce CD8+ T cell activity [51]. This evidence concerns the gene CD69 and head and neck cancer.